Metolazone – switching to Xaqua®
Xaqua® brand is licensed and should be used first line. All metolazone products should be prescribed by brand name and must not be switched without careful dose titration, due to the differences in bioavailability...
Category: News
Ukrainian Medicines Resources for Healthcare Professionals
In order to help Ukrainian patients, the Southampton Medicines Advice Service have compiled a list of useful resources which we are grateful to be able to share: The International Pharmacy Federation (FIP) has produced...
National Antiviral Service Cymru (NAVS) – new websites
The National Antiviral Service (NAVS) has two new pages on this site. Information for members of the public can be found at Healthcare professionals can access additional information to assist their clinical decisions at
New national COVID-19 treatment Patient Group Directions (PGDs)
The new national COVID-19 treatment Patient Group Directions (PGDs) for casirivimab and imdevimab, sotrovimab, and molnupiravir are now available for adaptation by NHS Wales Local Health Boards. You can access these via our Publications...
Meet the team
Medication Safety Officer (MSO) – Cardiff and Vale UHB Hi, I’ve been asked to share with you my experience in the role of Medication Safety Officer (MSO) – a part of my job I...
New Tocilizumab PIL in Welsh
There is a new patient information leaflet in Welsh on tocilizumab treatment of COVID-19.
New Q&A – Is there a role for inhaled epoprostenol, inhaled nitric oxide or sildenafil to treat secondary pulmonary hypertension and hypoxaemia in ICU patients with acute respiratory distress syndrome?
There is a new UKMi Q&A – Is there a role for inhaled epoprostenol, inhaled nitric oxide or sildenafil to treat secondary pulmonary hypertension and hypoxaemia in ICU patients with acute respiratory distress syndrome?
Coronavirus (COVID-19) – Therapeutic advice via AWTTC.org
To aid in the appropriate use of medicines during the current Coronavirus (COVID-19) pandemic, AWTTC have provided therapeutic advice for information on the AWTTC.org website.
Updated Q&A – How should crusted and difficult-to-treat scabies be managed?
There is an update to the UKMi Q&A: How should crusted and other forms of difficult-to-treat scabies be managed?
Updated Q&A – Which commonly used nebuliser solutions are compatible?
There is an update to the UKMi Q&A for Which commonly used nebuliser solutions are compatible?
